Results 81 to 90 of about 11,153 (206)

Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study

Journal of Diabetes Research, 2015
Background. The concurrent use of a postprandial insulin sensitizing agent, such as bromocriptine-QR, a quick release formulation of bromocriptine, a dopamine D2 receptor agonist, may offer a strategy to improve glycemic control and limit/reduce insulin ...
Erin D. Roe, Bindu Chamarthi, Philip Raskin   +2 more
doaj   +1 more source

The Effects of Bromocriptine on Preventing Postpartum Flare in Systemic Lupus Erythematosus Patients from South China

Journal of Immunology Research, 2015
Objective. Prolactin plays an important role on the disease flare of postpartum SLE patients. 76 pregnant SLE patients were enrolled in this study to evaluate the efficacy of bromocriptine (an inhibitor of prolactin secretion) on preventing the ...
Qiu Qian, Liang Liuqin, Li Hao, Yuan Shiwen, Zhan Zhongping, Chen Dongying, Lian Fan, Xu Hanshi, Yang Xiuyan, Ye Yujin   +9 more
doaj   +1 more source

Therapeutic Effects of Bromocriptine in Idiopathic Parkinsonism

, 1984
Therapeutic eκects of bromocriptine were evaluated in 16 idiopathic Parkinsonism patients. 22.5mg of bromocriptine was added to the conventional antiparkinsonian agents including L-dopa, and clinical evaluation was performed according to the ...
이문규, 민헌기, 이상복
core  

Bromocriptine and its Antipyretic Effect in Central Hyperthermia

Galicia Clínica
Central hyperthermia is marked by rapid onset of elevated temperatures, resistant to antibiotics and antipyretics. Diagnosis requires exclusion of infectious sources and identification of an underlying neurological condition.
Sérgio Costa Monteiro, Bárbara Paracana, João Fonseca, Jorge Henriques   +3 more
doaj   +1 more source

The Effect of Bromocriptine on the Disease Activity Index in Patients with Rheumatoid Arthritis

مجله دانشکده پزشکی اصفهان, 2011
Background: Limited studies have shown that the administration of Bromocriptine leads to clinical improvement in a number of rheumatic patients. Low price of Bromocriptine and its trivial side effects lead the authors to investigating the effect of ...
Mansour Salesi, Somayeh Sadeghi Haddadzavareh, Peyman Nasri, Nasrin Namdari Gharaghani, Ziba Farajzadegan   +4 more
doaj  

Effect of Bromocriptine on the Left Ventricular Function in Patients with Peripartum Cardiomyopathy: A Single-center Prospective Cohort Study

Journal of Clinical and Preventive Cardiology
Context: Bromocriptine is in practice of prescribing for peripartum cardiomyopathy patients in the hospital. However, prospective studies demonstrating the effect of bromocriptine on the LV function were lacking. Aims: The aim of this study was to assess
Narendra Sreekanth Tirumala, V Lalitha Kumari, K Ravi Kiran, B Kiran Kumar Reddy, P Prasanth, K Satya Kumar, Punugupati Mahesh, S Pervez Nawaz, Ravikishore Pallanti   +8 more
doaj   +1 more source

Chronically elevated sympathetic nervous system tone: A significant, common, and poorly realised contributor to cardiometabolic disease in type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1595-1598, March 2026.
Ralph A. DeFronzo
wiley   +1 more source

Bromocriptine in the Rett syndrome.

, 1990
Twelve typical cases of the Rett syndrome and one forme fruste were treated with bromocriptine for six months and then had a washout for two months followed by resumption of the bromocriptine treatment. During the first bromocriptine treatment there were
M. Zappella, FACCHINETTI, Fabio, G. Hayek, A. Genazzani   +3 more
core  

Transdermal Administration of Bromocriptine.

Biological and Pharmaceutical Bulletin, 2003
Bromocriptine (BRC) has been mainly used for the inhibition of lactation, treatment of menstrual disorders, Parkinson disease, breast tumours, infertility and brain tumours as a dopamine agonist in clinics. But current BRC formulations have some side effects and bioavailability problems because of hepatic first pass effect.
Lortlar, ND, Degim, LT, Acarturk, FÜSUN, Erdogan, D   +3 more
openaire   +4 more sources

Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).

, 1978
Bromocriptine produces long-lasting hypomotility and decreases brain dihydroxyphenylacetic acid (DOPAC) in mice. These effects are obtained with doses much lower than those which produce hypermotility.
DI CHIARA, GAETANO, Porceddu M. L, Vargiu L, Gessa G. L.   +3 more
core   +1 more source